| scholarly article | Q13442814 |
| P50 | author | Francis Rodier | Q58885077 |
| P2093 | author name string | Inés Colmegna | |
| Dominique Shum-Tim | |||
| Stéphanie Nadeau | |||
| Felipe Apablaza | |||
| Reggie Hamdy | |||
| Audrey Carrier-Leclerc | |||
| Kelsey O'Hagan-Wong | |||
| P2860 | cites work | PML regulates p53 acetylation and premature senescence induced by oncogenic Ras | Q22254666 |
| Hematopoietic stem cell niche maintenance during homeostasis and regeneration | Q26865273 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Accumulation of Checkpoint Protein 53BP1 at DNA Breaks Involves Its Binding to Phosphorylated Histone H2AX | Q28191330 | ||
| Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders | Q28252088 | ||
| Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer | Q28384025 | ||
| Parathyroid hormone mediates hematopoietic cell expansion through interleukin-6 | Q28592017 | ||
| Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor | Q29615559 | ||
| A DNA damage checkpoint response in telomere-initiated senescence | Q29615919 | ||
| Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells. | Q30318835 | ||
| The bone marrow at the crossroads of blood and immunity | Q33581299 | ||
| Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis | Q33646411 | ||
| DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion | Q33759285 | ||
| Cellular and molecular aspects of human CD34+ CD38- precursors: analysis of a primitive hematopoietic population | Q34011542 | ||
| Four faces of cellular senescence. | Q34025754 | ||
| Cellular senescence and the senescent secretory phenotype: therapeutic opportunities | Q34035882 | ||
| The role of senescent cells in ageing | Q34041036 | ||
| Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice | Q34045591 | ||
| The aged niche disrupts muscle stem cell quiescence. | Q34302715 | ||
| Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia model. | Q34401933 | ||
| An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA | Q34453396 | ||
| Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells | Q34652128 | ||
| Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells | Q34768188 | ||
| Dampened ERK signaling in hematopoietic progenitor cells in rheumatoid arthritis | Q35830840 | ||
| AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. | Q35849653 | ||
| Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression | Q35930081 | ||
| MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation | Q36405926 | ||
| Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. | Q37345878 | ||
| Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation. | Q37493543 | ||
| Regulation of hematopoietic stem cells by bone marrow stromal cells | Q37626327 | ||
| DDR-mediated crosstalk between DNA-damaged cells and their microenvironment. | Q38393118 | ||
| Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. | Q41468517 | ||
| Co-culture with mesenchymal stromal cells increases proliferation and maintenance of haematopoietic progenitor cells | Q41866922 | ||
| Manipulating senescence in health and disease: emerging tools | Q43208845 | ||
| The effect of age on human adipose-derived stem cells | Q44182329 | ||
| Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells | Q46286017 | ||
| Isolation of human mesenchymal stem cells from bone and adipose tissue | Q47743409 | ||
| Interleukin-6 induces the lineage commitment of bone marrow-derived mesenchymal multipotent cells through down-regulation of Sox2 by osteogenic transcription factors | Q47890725 | ||
| Gamma radiation induces senescence in human adult mesenchymal stem cells from bone marrow and periodontal ligaments. | Q53184654 | ||
| Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes. | Q54348216 | ||
| Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment | Q58379782 | ||
| Telomere dysfunctional environment induces loss of quiescence and inherent impairments of hematopoietic stem cell function | Q83344193 | ||
| Age-related changes in human hematopoietic stem/progenitor cells | Q83648455 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 13285-13296 | |
| P577 | publication date | 2016-03-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Increased IL-6 secretion by aged human mesenchymal stromal cells disrupts hematopoietic stem and progenitor cells' homeostasis | |
| P478 | volume | 7 |
| Q38962768 | A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis |
| Q52717549 | Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes. |
| Q92152784 | Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic Disorders |
| Q89447778 | Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing |
| Q47150310 | Effects of acute exposure to low-dose radiation on the characteristics of human bone marrow mesenchymal stromal/stem cells |
| Q64060124 | Experimental Strategies of Mesenchymal Stem Cell Propagation: Adverse Events and Potential Risk of Functional Changes |
| Q92820179 | Impact of mesenchymal stem cell senescence on inflammaging |
| Q47116205 | Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells |
| Q55340999 | Interferon-Gamma Impairs Maintenance and Alters Hematopoietic Support of Bone Marrow Mesenchymal Stromal Cells. |
| Q92240728 | Kupffer Cells Promote the Differentiation of Adult Liver Hematopoietic Stem and Progenitor Cells into Lymphocytes via ICAM-1 and LFA-1 Interaction |
| Q41430358 | Microvesicles as Potential Biomarkers for the Identification of Senescence in Human Mesenchymal Stem Cells |
| Q37671165 | Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways |
| Q41549055 | Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade |
| Q49343380 | Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis |
| Q57042168 | Transplanted human pluripotent stem cell-derived mesenchymal stem cells support liver regeneration in Gunn rats |
Search more.